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arge-scale proteomic and functional analysis of isolated
pseudopodia revealed the Lim, actin, and SH3 domain
protein (Lasp-1) as a novel protein necessary for cell
migration, but not adhesion to, the extracellular matrix
(ECM). Lasp-1 is a ubiquitously expressed actin-binding
protein with a unique domain conﬁguration containing
SH3 and LIM domains, and is overexpressed in 8–12% of
human breast cancers. We ﬁnd that stimulation of nonmotile
and quiescent cells with growth factors or ECM proteins
facilitates Lasp-1 relocalization from the cell periphery to
the leading edge of the pseudopodium, where it associates
L
 
with nascent focal complexes and areas of actin polymer-
ization. Interestingly, although Lasp-1 dynamics in migratory
cells occur independently of c-Abl kinase activity and
tyrosine phosphorylation, c-Abl activation by apoptotic
agents speciﬁcally promotes phosphorylation of Lasp-1 at
tyrosine 171, which is associated with the loss of Lasp-1
localization to focal adhesions and induction of cell death.
Thus, Lasp-1 is a dynamic focal adhesion protein necessary
for cell migration and survival in response to growth factors
and ECM proteins.
 
Introduction
 
The direction of cell migration is controlled by chemokine
and ECM gradients, and is exhibited during wound healing,
angiogenesis, embryonic development, and immune function
(Lauffenburger and Horwitz, 1996). Cells respond by local
activation and amplification of signaling events on the side
facing the attractant (Parent and Devreotes, 1999). This
facilitates localized actin polymerization leading to morpho-
logical polarity and establishment of a dominant-leading
pseudopodium and rear cell body compartment (Lauffenburger
and Horwitz, 1996; Parent and Devreotes, 1999). Interest-
ingly, the initial protrusion of a pseudopodium at the cell
surface is independent of integrins and the ECM (Wyckoff et
al., 2000). However, integrins tether the extending membrane
to the substratum, which supports sustained and directional
growth of a single dominant pseudopodium. Indeed, a
pseudopodium that does not attach to the ECM rapidly
retracts back to the cell body (Bailly et al., 1998). This
suggests that formation of new integrin focal complexes at
the leading front of the extending membrane provides necessary
signals to fine-tune and maintain directional growth, while
suppressing retraction mechanisms. Cell movement then
commences as the cell undergoes repeated cycles of mem-
brane extension and integrin ligation at the front and cell
body retraction at the rear (Lauffenburger and Horwitz,
1996). The specific signaling proteins that regulate the spatial
adhesive changes necessary for morphological polarity and
directional cell translocation are poorly understood.
To help unravel the spatiotemporal organization of signaling
cascades involved in cell polarization, including mechanisms
of protein translocation, activation, post-translational modi-
fications, and formation of complex multi-protein scaffolds,
we developed a biochemical method to selectively isolate the
pseudopodium and cell body of cells polarized toward a
chemoattractant gradient using a microporous filter sys-
tem (Cho and Klemke, 2002; Brahmbhatt and Klemke,
2003). Pseudopodia extension in this system, like traditional
pseudopodia formation on two-dimensional surfaces, requires
Cdc42 and Rac activity and shows normal actin cytoskeletal
organization and focal adhesions. Cells extend pseudopodia
projections through small openings in the vasculature and
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ECM in vivo as a necessary process of immune cell intrava-
sation as well as pathological processes associated with can-
cer cell metastasis (Wyckoff et al., 2000). Therefore, this
model recapitulates physiological events associated with cell
migration and is ideal for unraveling the spatial and tempo-
ral signaling mechanisms responsible for focal adhesion
changes leading to cell polarity and directional movement.
In this report, we used this technique along with a new
protein sequencing method called multidimensional protein
identification technology (MudPIT; Washburn et al., 2001)
for rapid and large-scale proteome analysis of purified pseu-
dopodia. By using multidimensional liquid chromatog-
raphy, tandem mass spectrometry, and database searching
with SEQUEST algorithm, it is possible to identify large
numbers of proteins (
 
 
 
1,000) directly from a complex pro-
tein lysate (Washburn et al., 2001). Here, we isolated
pseudopodia and cell body proteins for comparison by Mud-
PIT to reveal proteins uniquely present in these different cel-
lular compartments. The novel cytoskeletal-associated Lim,
actin, and SH3 protein (Lasp-1; GenBank/EMBL/DDBJ ac-
cession no. X82456) was identified as a component of the
pseudopodium and further characterized for functional sig-
nificance. Lasp-1 was initially identified from a breast can-
cer–derived metastatic lymph node cDNA library and is
overexpressed in 8–12% of breast cancer (Tomasetto et al.,
1995a,b). It is a ubiquitously expressed actin-binding protein
with a unique domain configuration (Tomasetto et al.,
1995a; Schreiber et al., 1998) that includes a LIM domain
(
 
Lin
 
11, 
 
Isl
 
-1, and 
 
Mec
 
-3) in the NH
 
2
 
-terminal region fol-
lowed by two actin-binding repeats (R1, R2), and an Src ho-
mology 3 (SH3) domain in the COOH-terminal region.
There are also two tyrosine phosphorylation sites (Y52
and Y152) corresponding to SH2-binding consensus motifs
(YXXP; Tomasetto et al., 1995a), suggesting that Lasp-1 is
tyrosine phosphorylated and may facilitate binding of SH2
effector proteins and their downstream signals. However, the
biological function and regulation of this molecule has not
yet been identified. Our findings demonstrate that Lasp-1 is a
dynamic, spatially regulated protein necessary for cell migra-
tion. Furthermore, we show that the cytoskeletal regulatory
 
Table I. 
 
Proteins identified in purified pseudopodia
 
a
 
Cytoskeletal-associated proteins Number of 
identified peptides
 
 
 
-Actinin 7
Tropomyosin 1 16
 
 
 
-4-Tubulin 10
 
 
 
-Actin 29
Transgelin 2 9
Lim and SH3 protein (Lasp-1) 1
Myosin 1B and C 1
Cofilin 1 and 2 1
Arp1 and 3 1
Caldesmon 1
Drebrin 1, isoform a and b 1
Filamin 1
Fascin 1
Adenomatous polyposis coli–binding 
protein EB1
1
 
Signaling proteins
 
Rho guanine nucleotide exchange factor 1 1
PI 3-kinase–related kinase SMG-1 1
Guanine nucleotide binding protein, 
 
 
 
-type 1
RAB5A and C 1
A-kinase anchor protein 3 1
Oligophrenin 1, Rho-activating protein 1
Ca
 
  
 
/calmodulin-dependent protein kinase 2 
delta subunit
1
Insulin receptor substrate 1 1
Neuregulin 1: c-neu receptor 1
 
a
 
Complete list of all identified peptides and identified proteins in pseu-
dopodia and cell body fractions is shown in Tables S1–S4 and Fig. S1
(available at http://www.jcb.org/cgi/content/full/jcb.200311045/DC1).
Figure 1. Subcellular localization of Lasp-1 in spreading and 
migrating cells. (A) Pseudopodia and cell body fractions were purified 
as described in Materials and methods. 10  g of proteins were 
analyzed for relative expression of Lasp-1 by Western blotting using 
anti-Lasp-1 and anti-Erk2 antibodies, which served as a loading 
control. (B) Deconvolution images of NIH 3T3 cells transfected with 
GFP Lasp. Cells were allowed to attach and spread on fibronectin-
coated coverslips for 120 min or (C) to migrate into a wound for 18 h. 
Cells were fixed and stained with anti-vinculin antibodies to visualize 
focal adhesions. Merged images show colocalization (yellow) of 
focal adhesions (red) and GFP Lasp (green). Note that GFP Lasp 
strongly localized to focal adhesions proximal to the cell edge at the 
leading front of the pseudopodium. Arrow indicates the direction 
of cell migration. Bar, 28  m. 
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protein c-Abl tyrosine kinase (Woodring et al., 2003) directly
phosphorylates Lasp-1, which regulates its localization to fo-
cal adhesions in apoptotic (but not migratory) cells.
 
Results
 
Characterization of the pseudopodial proteome and 
identification of Lasp-1
 
The ability to differentially isolate proteins from the leading
pseudopodium and cell body and the recent development of
MudPIT technology allowed us undertake large-scale pro-
teomics to characterize the pseudopodium and cell body
proteomes. Five independent cell body and pseudopodial
fractions were prepared and examined by MudPIT. From
the tandem mass spectroscopy data, we generated 4,000
peptides leading to the identification of 980 total proteins.
Although mass spectroscopy and MudPIT systems are lim-
ited in their ability to directly quantify proteins, they can be
used to identify relative differences in protein profiles of two
separate protein samples because an enriched protein will re-
sult in higher peptide identification. We considered a pro-
tein to be enriched if at least one peptide was identified in a
fraction or at least 50% more peptides were sequenced in a
given fraction. Comparison of the 980 proteins using DTA-
select and Contrast software (Tabb et al., 2002) revealed
119 enriched proteins in the pseudopodial fraction and 203
enriched proteins in the cell body component. Notable pro-
teins previously shown to be enriched in the pseudopodium
of cells are shown in Table I, demonstrating the feasibility of
this approach (a comparative list of all pseudopodia and cell
body–associated proteins is shown in Tables S1–S4 and
Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200311045/DC1). Of the proteins identified, Lasp-1
was further characterized for functional significance. West-
ern blot analysis and densitometry confirmed that Lasp-1
protein was increased (approximately ninefold) in the pseu-
dopodium compared with the cell body (Fig. 1 A). A Lasp-1
GFP fusion also revealed striking localization to the leading
pseudopodial edge of spreading and migrating cells (Fig. 1,
B and C). A similar pattern of Lasp-1 localization was ob-
served using immunofluorescent staining and Lasp-1 anti-
bodies (unpublished data; see also Chew et al., 2002). These
findings confirm the purification and identification of this
protein from the MudPIT system and demonstrate its local-
ization to the leading pseudopodium of polarized cells.
 
Cell adhesion and exposure to growth factors induce 
the translocation of Lasp-1 from the cell periphery to 
focal complexes in migrating cells
 
It is notable that GFP Lasp colocalized to vinculin-positive
focal adhesions primarily at the leading edge of the spread-
ing membrane and was either absent or reduced in focal ad-
hesions in the cell body proper (Fig. 1). In nonmotile se-
rum-starved cells, Lasp-1 localized to the peripheral edge of
Figure 2. Lasp-1 is a dynamic protein that transits 
from the cell periphery to focal adhesions upon 
stimulation with growth factors. (A) Deconvolution 
images of NIH 3T3 cells transfected with GFP Lasp 
and stained for vinculin-positive focal adhesions 
as described in Materials and methods. Cells were 
serum starved overnight ( serum) and stimulated 
with 10% FBS for 15 min. Merged images represent 
colocalization (yellow) of focal adhesions (red) and 
GFP Lasp (green). (B) GFP Lasp with its COOH-
terminal region truncated (GFP Lasp C) was 
examined for localization to focal adhesions upon 
serum stimulation as described in Materials and 
methods. Arrows indicate membrane ruffles. GFP 
Lasp C cells without serum showed a similar 
pattern of expression as of cells with serum 
(not depicted). (C) Schematic representation of 
the Lasp C and SH3 domain mutants (LaspSH3) 
used in this experiment and the experiments shown 
in Fig. 4 C. Bar, 28  m. 
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cells, where it colocalized with cortical actin structures and
weakly with F-actin cables (Fig. 2 A and Fig. 3), but not fo-
cal adhesions. However, exposure of these cells to growth
factors to activate cell migration caused the rapid (1–2 min)
relocalization of GFP Lasp from the cell periphery to focal
adhesions (Fig. 2 A). At later times after stimulation (
 
 
 
15
min), GFP Lasp strongly localized to actin-rich membrane
ruffles on the cell surface (Fig. 3).
Importantly, truncation of the COOH-terminal region of
Lasp-1 (GFP Lasp
 
 
 
C) prevented translocation of Lasp-1 to
focal adhesions (Fig. 2 B), but not to membrane ruffles, ac-
tin cables, or cortical actin structures in response to serum
(Fig. 2 B) or cell spreading on the ECM (unpublished data).
Thus, the COOH terminus of Lasp-1 is specifically respon-
sible for translocation and targeting to focal adhesions, but
not ruffles, in response to ECM proteins and growth factors.
Expression of GFP fused to either the LIM or SH3 domains
showed only diffuse cytoplasmic staining, suggesting these
domains are not sufficient by themselves to target Lasp-1 to
actin or focal adhesion structures under these conditions
(unpublished data).
 
Lasp-1 is necessary for cell migration (but not adhesion) 
to the ECM
 
Although the function of Lasp-1 is not known, the above
findings suggest that it is important for cell adhesion and
migration on the ECM. To directly examine this possibility,
we depleted cells of Lasp-1 using small interfering RNA
(siRNA) technology (Elbashir et al., 2001). Cells exposed to
anti-Lasp-1 siRNA showed an 
 
 
 
80–90% reduction in Lasp-1
protein compared with cells mock treated with control
siRNA directed to GL2 luciferase. Total protein staining
and Western blotting for either Lasp-1 or actin revealed that
only Lasp-1 was reduced and not other cellular proteins
(Fig. 4 A). Interestingly, although cells depleted of Lasp-1
showed little difference in adhesion and spreading, they did
show a significantly impaired ability to migrate on the ECM
(Fig. 4, A and B). These findings indicate that Lasp-1 pro-
tein is necessary for cell migration, but not cell adhesion and
spreading. Similar findings were obtained with NIH 3T3 fi-
broblast cells depleted of Lasp-1 protein (unpublished data).
Interestingly, Lasp-1 expression has been reported to be in-
creased in metastatic breast cancers, suggesting that protein
amplification may contribute to the migratory properties of
these cells (Tomasetto et al., 1995b). To investigate this, we
ectopically expressed Lasp-1 in cells and monitored their
ability to migrate in response to growth factors. Surprisingly,
Lasp-1 amplification inhibited basal and growth factor–
stimulated cell migration (Fig. 4 C) without affecting at-
tachment to the ECM (unpublished data). Similar findings
were obtained with HEK 293 (Fig. 4 D) and MCF-7 cells
(unpublished data). Importantly, expression of Lasp
 
 
 
C
failed to inhibit cell migration or adhesion, indicating that
the COOH-terminal region of Lasp-1 is required for this
process. Expression of the SH3 domain alone strongly inhib-
ited cell migration, which supports this notion (Fig. 4 C). It
is not yet clear why both depletion and amplification of
Lasp-1 inhibits cell migration. However, it is possible that
global amplification of Lasp-1 throughout the cell body dis-
rupts signaling polarity and the normal restricted localiza-
tion of this protein, as has been shown for Cdc42 (Allen et
al., 1998). In this regard, disruption of signaling polarity by
constitutive relocalization of Lasp-1 to the plasma mem-
brane caused dramatic membrane blebbing and detachment
from the ECM leading to cell death, whereas targeting of
Lasp
 
 
 
C to the membrane failed to induce this response (Fig.
4 E). In any case, these findings demonstrate that Lasp-1
plays an important spatial role in cell migration, and that
this process is regulated by the COOH-terminal region of
Lasp-1 containing the SH3 domain.
 
Abl kinase associates with the SH3 domain of Lasp-1 
and phosphorylates tyrosine 171 in vivo
 
Next, we performed a database and motif screen for poten-
tial regulatory proteins associated with Lasp-1 using the
SH3 domain and putative tyrosine phosphorylation sites in
the COOH terminus as targets. Lasp-1 was found to con-
tain a conserved Abl consensus phosphorylation sequence at
tyrosine 171 (VYxxP) and an SH3 domain that is predicted
to bind to the proline-rich region of Abl family kinase (Liu
et al., 1996; Wang et al., 1997; Barila et al., 2000). Further-
more, the fact that Abl and Arg regulate the actin cytoskele-
Figure 3. Lasp-1 localizes to cortical F-actin and 
actin cables in quiescent cells and dorsal membrane 
ruffles in serum stimulated cells. Deconvolution 
images of NIH 3T3 cells transfected with GFP Lasp 
and stained for F-actin with rhodamine-phalloidin. 
Cells were serum starved overnight (NT) and then 
stimulated with PDGF-BB for 30 min. Merged 
images represent colocalization (yellow) of F-actin 
(red) and GFP Lasp (green). Bar, 28  m. 
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ton, focal adhesions, and cell migration (Woodring et al.,
2003) suggests these proteins may be part of a common sig-
naling pathway. To begin to determine whether Abl and
Lasp-1 associate in vivo, cells were transfected with HA-
tagged Abl and full-length Lasp-1. HA-tagged Abl was then
immunoprecipitated from these cells and immunoblotted
for the presence of Lasp-1. In the reciprocal experiment,
GST Lasp was precipitated from transfected cells and immu-
noblotted for HA-Abl. In both cases, Abl associated with
and promoted increased tyrosine phosphorylation (
 
 
 
25-
fold) of Lasp-1 in cells (Fig. 5 A). Tyrosine phosphorylation
of Lasp-1 was accompanied by reduced mobility in SDS-
PAGE, as indicated by the appearance of a higher molecular
weight form of Lasp-1. This was also the case when purified
activated Abl was allowed to phosphorylate bacterial purified
Lasp-1 in vitro (Fig. 5 E). Importantly, Lasp
 
 
 
C without the
Abl binding and phosphorylation site Y171 failed to associ-
ate with Abl and showed no tyrosine phosphorylation as the
result of Abl activation (Fig. 5, A and B). As expected, Abl
with a truncated proline-rich domain (Abl
 
 
 
Pro; Smith et
al., 1999) failed to interact and phosphorylate Lasp-1 in cells
(Fig. 5 C). Wild-type Abl and Abl
 
 
 
Pro become auto-acti-
vated in cells due to protein amplification as previously re-
ported (Smith et al., 1999; Kain and Klemke, 2001; Kain et
al., 2003). In this regard, the constitutively activated onco-
genic form of Abl (Bcr-Abl; Daley et al., 1990) tyrosine
phosphorylates GST Lasp in cells (Fig. 5 D). K562 leukemic
cells derived from a CML patient with endogenous Bcr-Abl
(Grosveld et al., 1986) also show increased Lasp-1 tyrosine
phosphorylation (unpublished data). As expected, exposure
of cells to the Abl kinase inhibitor STI 571 (Buchdunger et
al., 1996) inhibited Lasp-1 tyrosine phosphorylation, indi-
cating that kinase activity is necessary for this event (Fig. 5
D). Most importantly, substitution of tyrosine 171 to phe-
Figure 4. Lasp-1 is necessary for cell migration, but not adhesion to the ECM. (A) Cos-7 cells were depleted of endogenous Lasp-1 protein 
using siRNA specific for Lasp-1 or control siRNA to GL2 luciferase. Cells were allowed to either migrate using Boyden chambers coated on 
the bottom with 10  g/ml fibronectin or (B) to attach to culture dishes coated with the same ECM as described in Materials and methods. 
The number of migratory or adherent cells per microscopic field was counted. Each bar represents the mean   SEM of cells in triplicate 
migration/adhesion chambers of three independent experiments. An aliquot of cell lysates prepared from cells treated as described above 
were Western blotted for expression of Lasp-1 or actin, which served as a loading control. (C) COS-7 cells were transfected with the empty 
vector (Mock), wild-type Lasp-1 (Wt), Lasp C ( C), or the SH3 domain tagged with HA (SH3) along with a  -galactosidase reporter construct 
to mark transfected cells. Cells were allowed to chemotax with or without LPA in the lower chamber for 3 h. Migratory cells per microscopic 
field on the underside of the membrane were stained and counted. Each bar represents the mean   SEM of blue cells in triplicate migration 
chambers of three independent experiments. An aliquot of cell lysates prepared from cells treated as described above were Western blotted for 
the expression of the appropriate protein or tag as indicated. (D) HEK 293 cells stably expressing the empty vector (mock) or the vector encoding 
full-length Lasp-1 were tested for chemotaxis with or without 10  g/ml insulin in the lower chamber as indicated in C. Lasp-1 protein was 
Western blotted to confirm the protein expression. HEK 293 cells show low levels of endogenous Lasp-1 protein, which is not detected in the 
short exposure time to the film. (E) Deconvolution images of COS-7 cells transfected with either Lasp-1 or Lasp C fused with the membrane-
targeting sequence (myr) along with a GFP reporter construct. Cells were then fixed and examined for membrane blebs 16 h after transfection, 
and the number of transfected cells with prominent blebs were counted per microscopic field relative to the total number of GFP-positive cells. 
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nylalanine (LaspY171F) prevented Lasp-1 tyrosine phos-
phorylation and mobility shift by Abl activation (Fig. 5 F).
The remaining phosphoprotein band seen in the LaspY171F
and HA-Abl cells likely represents endogenous Lasp-1 phos-
phorylated by Abl. These findings demonstrate the in vivo
association of Abl with the COOH-terminal region of Lasp-1,
and confirms tyrosine 171 is the site of phosphorylation in-
duced by Abl activation in cells.
 
Abl specifically phosphorylates Lasp-1 in apoptotic 
(but not migratory) cells, and this prevents Lasp-1 
translocation to focal complexes
 
Abl is activated by exposure of cells to growth factors and
through integrin activation processes that occur during cell
spreading on the ECM (Lewis et al., 1996; Plattner et al.,
1999). Like Lasp-1, Abl is a dynamic protein that translo-
cates to focal adhesions and membrane ruffles under these
conditions (Woodring et al., 2003). Therefore, we investi-
gated whether Lasp-1 was tyrosine phosphorylated in cells
treated with growth factors (FBS, EGF, and PDGF-BB) or
in cells spreading on the ECM. However, although these
stimuli caused Lasp-1 translocation to focal adhesions and
membrane ruffles (Figs. 1–3), they did not induce tyrosine
phosphorylation of Lasp-1 (unpublished data). Further-
more, STI 571 did not inhibit Lasp-1 translocation to focal
complexes under these conditions (see Fig. 7). Together,
these findings demonstrate that Abl activation and tyrosine
phosphorylation of Lasp-1 by themselves do not play a pri-
mary role in Lasp-1 localization to actin structures and focal
adhesions under these conditions.
Interestingly, Abl also induces cell apoptosis in response to
DNA-damaging agents (cisplatin; Gong et al., 1999) and
oxidative stress (H
 
2
 
O
 
2
 
; Sun et al., 2000). Although the
mechanisms are not yet understood, the death process in-
Figure 5. Abl kinase associates with the COOH terminus of Lasp-1 and tyrosine phosphorylates Y171. (A) COS-7 cells were transfected 
with HA-Abl together with Lasp-1 or Lasp C. HA-Abl was immunoprecipitated and Western blotted for associated Lasp-1 protein with anti-Lasp-1 
antibodies. The blot was then stripped and reprobed for phosphotyrosine (PY). Western blots of whole-cell lysates are included to confirm 
expression of the appropriate protein (bottom). (B) GST-tagged Lasp or GST Lasp C was precipitated with glutathione beads and Western 
blotted for associated Abl protein with anti-HA antibodies from COS-7 cells expressing these constructs. Blots were stripped and reprobed for 
PY as indicated above, and whole-cell lysates were included to confirm protein expression. (C) GST Lasp was precipitated and Western blotted 
for associated Abl or Abl without its polyproline domain (Abl Pro) using anti-Abl antibodies. The blot was then stripped and blotted for PY to 
detect Lasp-1 phosphorylation. The expression levels of wild-type Abl and Abl pro in whole-cell lysates are shown below. (D) Bcr-Abl–transformed 
NIH 3T3 cells ( ) and mock control NIH 3T3 cells ( ) transfected with GST Lasp were starved and treated with 2  M STI 571 or buffer only 
for 16 h. GST Lasp was precipitated and Western blotted using anti-phosphotyrosine antibodies and then was stripped and reprobed with 
GST-specific antibodies. (E) Purified activated Abl was incubated with bacterial purified GST Lasp in the presence of ATP and kinase reaction 
buffer or purified GST alone as a control. Western blotting with phosphotyrosine, GST, or Lasp-1 was performed as indicated. (F) Cos-7 cells 
with or without HA-Abl were transfected along with Lasp-1 or Lasp with the Abl consensus tyrosine phosphorylation site Y171 substituted 
with phenylalanine (LaspY171F). Lasp-1 from these cells was Western blotted using anti-phosphotyrosine or Lasp-1-specific antibodies. 
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volves deregulation of the actin cytoskeleton and focal adhe-
sions during the execution phase of death (Huot et al., 1998;
Houle et al., 2003). Indeed, exposure of cells to either H
 
2
 
O
 
2
 
or cisplatin caused strong Lasp-1 tyrosine phosphorylation
that required endogenous Abl kinase activity (Fig. 6). More-
over, H
 
2
 
O
 
2
 
-induced Lasp-1 phosphorylation was signifi-
cantly impaired in embryonic mouse fibroblast cells isolated
from 
 
abl
 
 
 
/
 
 
 
arg
 
 
 
/
 
 
 
 animals, compared with these cells stably
reconstituted with Abl (Fig. 6 B). However, at later times
(
 
 
 
45 min) a small level of Lasp-1 phosphorylation is de-
tected, suggesting that another kinase(s) may phosphorylate
Lasp-1. Similar findings were obtained with cells treated
with pervanadate, which strongly (
 
 
 
17-fold) activates Abl
(unpublished data; Woodring et al., 2003). These findings
Figure 6. Apoptotic agents induce tyrosine phos-
phorylation of Lasp-1, and this requires Abl and Arg 
kinase activity. (A) Cos-7 cells transfected with GST 
Lasp were treated with 1 mM H2O2 for the indicated 
times in the presence or absence of 5  M STI 571. 
GST Lasp was precipitated and Western blotted using 
anti-phosphotyrosine or GST antibodies. (B) Embryonic 
fibroblast cells isolated from abl
 / arg
 /  animals or 
these cells stably reconstituted with Abl were transfected 
with GST Lasp and were then serum starved and treated 
with 1 mM H2O2 for the indicated times. GST Lasp 
expression and tyrosine phosphorylation were determine 
as described above. (C) Cos-7 cells transfected with 
GST Lasp were incubated with 25  M cisplatin for the 
indicated times in the presence or absence of 2  M 
STI 571. Lasp-1 expression and tyrosine phosphorylation 
were determined as described above.
Figure 7. Tyrosine phosphorylation Y171 of 
Lasp-1 prevents its translocation from the cell 
periphery to focal adhesions in response to growth 
factor stimulation. Deconvolution images of NIH 
3T3 cells expressing GFP Lasp or GFP LaspY171F 
were treated for 30 min with 1 mM H2O2 and for 
15 min with FBS. Cells were fixed and stained with 
anti-vinculin antibodies to visualize focal adhesions 
as described above. In some cases, GFP Lasp trans-
fected cells were preincubated with 5  M STI 571 
before H2O2 and FBS treatment to block Abl kinase 
activity as described in Materials and methods. 
Merged images represent colocalization (yellow) 
of focal adhesions (red) and GFP Lasp (green). 
Bars: 28  m (right and left panels) and 20  m 
(middle panel). 
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demonstrate the tyrosine phosphorylation of Lasp-1 by en-
dogenous Abl activation in response to apoptotic agents.
It is intriguing that the exposures of cells to survival fac-
tors like serum and PDGF-BB cause Lasp-1 to translocate
from the cell periphery to focal adhesions in an unphospho-
rylated state (Fig. 2). This suggests that translocation of un-
phosphorylated Lasp-1 to focal adhesions plays a role in
mediating survival signals through the cytoskeleton. If this
is the case, then phosphorylation of Lasp-1 by apoptotic
agents may prevent Lasp-1 localization to focal adhesions
and disrupt survival signals from these structures. To in-
vestigate this possibility, serum-starved cells expressing
GFP Lasp were briefly treated with H
 
2
 
O
 
2
 
 to induce Lasp-1
tyrosine phosphorylation, and were then stimulated with
growth factors to induce translocation of Lasp-1 to focal
adhesions and ruffles, as shown before (Fig. 2 A). H
 
2
 
O
 
2
 
strongly blocked GFP Lasp translocation to focal adhe-
sions, but not membrane ruffles, in response to growth fac-
tors (Fig. 7). Importantly, the short-term exposure of cells
to H
 
2
 
O
 
2
 
 only effected Lasp-1 translocation and did not
generally impact vinculin-positive focal adhesions, which
were similar to control cells (Fig. 7). Pretreatment of cells
with pervanadate also led to increased Lasp-1 tyrosine phos-
phorylation and prevented Lasp-1 translocation to focal ad-
hesions (unpublished data). Importantly, phosphorylation
of tyrosine 171 and Abl kinase activity were required for
the inhibitory response induced by H
 
2
 
O
 
2 
 
because cells ex-
pressing GFP LaspY171F or cells treated with STI 571
showed normal Lasp-1 translocation to focal adhesions
(Fig. 7). As expected, vehicle-treated cells expressing GFP
LaspY171F or cells treated with STI 571 showed normal
translocation of Lasp-1 to focal adhesions in response to
growth factors, as this process occurs independent of phos-
phorylation (unpublished data). It is noteworthy that GFP
LaspY171F did not constitutively translocate to focal adhe-
sions in the absence of growth factors (Fig. 7). This suggests
that basal phosphorylation of Y171 is not a general mecha-
nism used by the cell to regulate focal adhesion targeting of
Lasp-1 in healthy cells, but rather is a specific mechanism
that operates downstream of apoptotic stimuli and Abl ty-
rosine kinase activity. Importantly, although Abl-mediated
tyrosine phosphorylation blocked focal adhesion targeting
of Lasp-1 in apoptotic cells, it did not impact its transloca-
tion to membrane ruffles. Indeed, treatment of cells with
H
 
2
 
O
 
2
 
 or pervanadate did not prevent Lasp-1 localization to
actin-rich membrane ruffles in response to growth factors,
indicating that translocation to this subcellular structure is
not, per se, regulated by tyrosine phosphorylation (unpub-
lished data). These findings also demonstrate that H
 
2
 
O
 
2
 
does not globally block growth factor–induced signaling in
these cells. It appears, then, that apoptotic stimuli that
induce Abl activation promote Lasp-1 phosphorylation,
which specifically prevents Lasp-1 localization to focal ad-
hesions, but not ruffles. Conversely, under conditions that
promote cell survival and motility, Lasp-1 is not phosphor-
ylated and is strongly localized to focal adhesions as well as
ruffles. Most importantly, Lasp-1 directly contributes to
H2O2- and cisplatin-induced apoptosis because cells de-
pleted of Lasp-1 protein by siRNA show significantly in-
creased death in response to these apoptotic agents com-
pared with control cells expressing Lasp-1 protein (Fig. 8).
In contrast, apoptosis induced with the deacetylase inhibi-
tor trichostatin A (TSA; Ruefli et al., 2001) occurred inde-
pendent of Abl and Lasp-1 activity, and did not involve
changes in tyrosine phosphorylation of Lasp-1 or c-Crk
protein, a known endogenous substrate of Abl (Kain and
Klemke, 2001; Fig. 8, C–E). Thus, phosphorylation of
Lasp-1 is not a general response in cells undergoing apopto-
sis, but rather is a specific event related to Abl-dependent
apoptosis. In support of this, cells expressing LaspY171F,
which cannot be phosphorylated by Abl and readily transits
to focal adhesions, show reduced apoptosis in response to
cisplatin and H2O2, but not TSA (Fig. 9). Together, our
findings indicate that phosphorylation of Lasp-1 at tyrosine
Figure 8. Depletion of Lasp-1 protein increases cell apoptosis 
induced by H2O2 and cisplatin, but not TSA. COS-7 cells were 
depleted of endogenous Lasp-1 protein using siRNA specific for 
Lasp-1 or control siRNA to GL2 luciferase as described in the 
Materials and methods. Cells were plated onto fibronectin-coated 
glass coverslips, and were treated with either (A) 25  M cisplatin, 
(B) 1 mM H2O2, or (C) 300 ng/ml TSA for 24 h, or were treated with 
the indicated vehicle. (D) Cells were treated with or without (NT) 
H2O2 or TSA as described above in the presence or absence of 5 
 M STI 571. Apoptotic cells were determined after 24 h by staining 
with propidium iodide and counting the number of cells per micro-
scopic field with condensed nuclei as described previously (Kain et 
al., 2003). The bars represent the mean   SEM of three independent 
experiments. (E) COS-7 cells were treated with 300 ng/ml TSA or 
with DMSO for 24 h, and were then lysed in detergent and Western 
blotted for the indicated proteins. Note that TSA does not induce 
a mobility shift of c-CrkII and Lasp-1 protein, indicating that these 
proteins are not phosphorylated and Abl kinase is not activated 
under these apoptotic conditions. Asterisk shows the cleaved form 
of PARP, indicating that TSA induced apoptosis in these cells. The 
top band is a nonspecific protein that served as a loading control.Cell survival and migration by Lasp-1 | Lin et al. 429
171 prevents localization to focal adhesions and the loss of
survival signals and induction of cell death.
Discussion
Cell migration is characterized by morphological polariza-
tion with a dominant-leading pseudopodium and a tail re-
gion at the rear of the cell (Lauffenburger and Horwitz,
1996; Palecek et al., 1996). This process requires temporal
and spatial organization of signal transduction processes that
regulate actin polymerization and focal adhesion turnover.
In this report, we used a novel method to isolate the leading
pseudopodium from the cell body for biochemical analysis.
The unique ability to fractionate the pseudopodium com-
bined with recent advances in mass spectrometry that facili-
tate large-scale protein identification of complex protein
samples allowed us to compare the relative protein profiles
of these two subcellular compartments (Washburn et al.,
2001; Cho and Klemke, 2002). We identified several previ-
ously associated pseudopodial proteins including filamin,
tropomyosin, caldesmon, cofilin, Arp2/3, myosin 1B and C,
PI3K, and  -actinin, demonstrating the feasibility of this
approach (Conrad et al., 1989; Aizawa et al., 1997; Helfman
et al., 1999; Bailly et al., 2001; Laukaitis et al., 2001; Coo-
per, 2002; Funamoto et al., 2002). Although numerous
pseudopodial and cell body proteins were identified by
MudPIT, they represent only a small portion of the complex
proteome of these structures. Nevertheless, with the rapid
advances in mass spectrometry to quantify and monitor
complex post-translational modifications of proteins (Wash-
burn et al., 2001), together with fractionation into choles-
terol-rich membrane and detergent soluble/insoluble com-
ponents, will provide more detailed information on the
pseudopodial proteome, and will help unravel the complex
signal transduction events that control this cellular structure.
We chose to characterize Lasp-1 because its biological
function is not known. In this report, we provide several
lines of evidence that demonstrate Lasp-1 is a dynamic pro-
tein that transits to focal adhesions and is necessary for
proper cell migration. First, depletion of Lasp-1 protein
from cells strongly inhibits cell migration in response to
ECM proteins. The inhibitory effect is specific to migration,
as cell attachment and spreading appear normal in cells
without Lasp-1 protein. Second, exogenous amplification of
Lasp-1 also inhibits cell migration, but not adhesion and
spreading. We believe that exogenous expression of Lasp-1
disrupts its normal signaling polarity. Lasp-1 is strongly po-
larized in migrating cells, where it localizes to the leading
edge of the pseudopodium and to nascent focal adhesions in
this structure, but not the central body of the cell. That con-
stitutive relocalization of Lasp-1 to the plasma membrane
strongly induced membrane blebbing and detachment from
the ECM supports this idea. Third, stimulation of nonmi-
gratory cells with growth factors or ECM proteins that in-
duce cell migration cause the rapid relocalization of Lasp-1
from the peripheral membrane to a subset of focal adhesions
in the spreading edge of the pseudopodium. Because cells
depleted of Lasp-1 still attach to the ECM and form focal
adhesions, it would appear that Lasp-1 plays a supportive
role in focal adhesion dynamics during cell migration rather
than in the actual formation of these structures. That Lasp-1
localizes to focal adhesions at the tips of retracting tails of
migrating cells also supports this notion, as these adhesive
sites must turnover for proper cell body translocation and
tail release (Palecek et al., 1996). Together, these findings
demonstrate that Lasp-1 is a dynamic focal adhesion protein
necessary for cell migration.
Although the cellular factors responsible for translocation
of Lasp-1 to focal adhesions are not yet known, it appears
that the COOH-terminal region of Lasp-1 is critical for this
response. Our biochemical and time-lapse analyses (unpub-
lished data) of Lasp-1 indicate that translocation occurs rap-
idly within 1–2 min of growth factor stimulation and is in-
dependent of tyrosine phosphorylation. Indeed, repeated
attempts to demonstrate changes in tyrosine phosphoryla-
tion of Lasp-1, in response to ECM proteins or growth fac-
tors, failed to show this response, even though these factors
activate several tyrosine kinases including src and Abl (Lewis
et al., 1996; Plattner et al., 1999). Furthermore, we did not
detect a mobility shift of Lasp-1 in SDS-PAGE in stimu-
lated cells or purified pseudopodia, which is characteristic of
phosphorylation by PKA (Chew et al., 1998) as well as tyro-
sine phosphorylation (Fig. 6, A and B). This suggests that
phosphorylation does not regulate focal adhesion targeting
of Lasp-1 during cell spreading or pseudopodial extension.
However, in some cases PKA may regulate Lasp-1 in focal
Figure 9. Cells expressing LaspY171F show reduced apoptosis in response to cisplatin and H2O2, but not TSA. COS-7 cells were transfected 
with the empty vector (Mock), wild-type Lasp-1, or Lasp-1 with tyrosine 171 mutated to phenylalanine (LaspY171F) along with GFP, which 
served as a reporter for transfected cells. Cells were then treated with either (A) cisplatin, (B) H2O2, or (C) TSA, and the number of GFP-positive 
apoptotic cells was determined as described in Fig. 8. Bars represent the mean   SEM of three independent experiments.430 The Journal of Cell Biology | Volume 165, Number 3, 2004
adhesions as well as its association with actin in gastric pari-
etal cells where it localizes to the actin-rich canalicular mem-
brane (Chew et al., 2002; Butt et al., 2003). It is also possi-
ble that low levels of Abl and PKA activity regulate Lasp-1
dynamics in the microenvironment of the migrating cell,
but this activity was below biochemical detection in our
analyses.
Our findings indicate that the COOH-terminal portion
of Lasp-1 is for targeting to focal adhesions. The SH3 do-
main of Lasp-1 may play a pivotal role in focal complex tar-
geting, as these structures can direct proteins like p130CAS
(Crk-associated substrate) to focal adhesions (Harte et al.,
2000). However, a GFP fusion of the Lasp-1 SH3 domain
failed to translocate by itself to focal complexes (unpub-
lished data). It is possible that the GFP tag interfered with
the normal targeting function of this domain. Additional
truncations in the COOH terminus as well as point muta-
tions that disrupt SH3 domain function will be necessary to
pinpoint the region of Lasp-1 responsible for translocation
to focal complexes and for identification of binding proteins
that mediate this process. In any case, the Lim domain does
not play a critical role in focal adhesion targeting, as trunca-
tion of this domain did not prevent Lasp-1 localization to
these structures (unpublished data).
It is intriguing that Abl tyrosine kinase is activated by
growth promoting as well as by apoptotic stimuli (Lewis et
al., 1996; Gong et al., 1999; Plattner et al., 1999; Sun et al.,
2000). This suggests that Abl activity is a complex process
tightly regulated by temporal and spatial mechanisms that
couple to specific effector molecules. Our findings indicate
that growth factor/motility factors like serum, PDGF-BB,
EGF, and ECM proteins do not mediate coupling of Abl to
Lasp-1. Rather, Abl activation in response to apoptotic stim-
uli appears to selectively phosphorylate Lasp-1 on tyrosine
171, preventing its translocation into focal complexes. This
event is specific to focal complex targeting, as Abl-induced
phosphorylation of Lasp-1 does not inhibit its localization to
actin-rich structures including membrane ruffles and actin
cables. Thus, Abl-dependent tyrosine phosphorylation of
Y171 is a distinct signaling event that specifically blocks
Lasp-1 transiting to focal complexes in apoptotic cells.
Although the mechanism of Lasp-1 translocation is not
known, these findings have important implications, as Abl-
mediated death has been reported to involve nuclear and mi-
tochondrial events involving p53/p73 and cytochrome c re-
lease, respectively (Agami et al., 1999; Yuan et al., 1999;
Kumar et al., 2001; Goldberg et al., 2002). Our findings
suggest that Abl activation also targets cytoplasmic and focal
complex substrates in response to these apoptotic agents. An
early step in the apoptotic process involves remodeling of fo-
cal adhesions and detachment from the ECM (Mills et al.,
1999). Interestingly, an intermediate adhesive strength is
optimal for transmitting survival signals from focal adhe-
sions, suggesting that this process is tightly coupled to focal
adhesion dynamics and cell motility processes (Murphy-Ull-
rich, 2001; Truong et al., 2003). Prevention of Lasp-1 local-
ization to focal complexes by Abl may disrupt critical sur-
vival signals and may contribute to the execution phase of
the apoptotic response. Recent evidence indicates that cyto-
plasmic Abl inactivates the focal adhesion protein c-CrkII,
which induces apoptosis of carcinoma cells (Kain et al.,
2003). Interestingly, Abl coordinately regulates both the mi-
gration and apoptotic machineries of cells through c-CrkII
phosphorylation (Kain and Klemke, 2001; Kain et al.,
2003). However, we found that Abl only couples to Lasp-1
under conditions that induce cell apoptosis and not motility.
The ability of Abl to differentially target cytoplasmic and fo-
cal adhesion substrates like Lasp-1 and c-CrkII under migra-
tory or apoptotic conditions may be related to the duration
of kinase activation. Apoptotic agents tend to induce strong
and persistent Abl activity ( 1 h), whereas survival stimuli
like integrin and growth factor receptor activation typically
promote only a transient response ( 30 min; Lewis et al.,
1996; Gong et al., 1999; Plattner et al., 1999; Sun et al.,
2000). Interestingly, recent evidence indicates that integrins
and cell adhesion to the ECM is necessary for Abl-mediated
death in response to DNA-damaging agents like cisplatin
(Lewis et al., 2002; Truong et al., 2003). This suggests that
at least part of the Abl death signal requires integrins and fo-
cal adhesion structures. Although the kinetics of Abl activity
was not addressed in these reports, it seems reasonable that
part of the suicide program involves not only localization of
Abl to the nucleus where it regulates p53/73 (Lewis et al.,
2002; Truong et al., 2003), but also its localization to the
cytoplasm where it inactivates specific focal adhesion pro-
teins like Lasp-1 and c-CrkII. In this way, Abl activation
would have widespread impact on the apoptotic machineries
that operate at multiple compartments within the cell. This
widespread insult is likely important in the cell’s decision to
commit suicide or to attempt a repair and rescue program.
In any case, the current evidence indicates that Abl-medi-
ated death involves a cooperative effort with integrins, cyto-
skeleton, focal adhesions, and mitochondrial and nuclear
proteins. The challenge now is to understand how Abl coor-
dinately regulates these diverse processes and whether these
events contribute to cancer development and progression.
Materials and methods
Purification of pseudopodia and cell body fractions
and MudPIT analysis
Purification of pseudopodial proteins was according to published proce-
dures (Cho and Klemke, 2002). In brief, 1–1.5   10
6 NIH 3T3 cells were
allowed to extend pseudopodia toward an LPA gradient (100 ng/ml) for 60
min. A pseudopodia isolation kit (ECM 660; CHEMICON International) or
Costar chambers (tissue culture treated, 6.5-mm diam, 10- m thickness,
8- m pores, Transwell
®; Costar Corp.) were used for isolation. For Western
blotting, cells were rinsed in excess cold PBS and rapidly fixed in 100%
ice-cold methanol. Cell bodies on the upper membrane surface were man-
ually removed with a cotton swab and pseudopodia on the undersurface
scraped into lysis buffer (100 mM Tris, pH 7.4, 5 mM EDTA, 150 mM
NaCl, 1 mM sodium orthovanadate, and protease inhibitors [cocktail tab-
let; Roche]) containing the appropriate detergent for Western blotting
whole-cell lysates (1% SDS). Cell bodies were purified in a similar manner,
except pseudopodia on the undersurface were removed, and the cell body
on the upper surface was scraped into lysis buffer and detergent. For Mud-
PIT analysis, pseudopodia or cell bodies were scraped into PBS and the
soluble and insoluble fractions were digested for mass spectroscopy analy-
sis as described previously (Washburn et al., 2001).
Details of MudPIT and data analysis have been described elsewhere
(Washburn et al., 2001; Tabb et al., 2002). Tandem mass spectroscopy
spectra were searched against a combined database of human, mouse,
and rat proteins using SEQUEST, and the combined database was con-
structed from the NCBI protein database (August 20, 2002). The results
were further analyzed by DTASelect and Contrast software. Peptides withCell survival and migration by Lasp-1 | Lin et al. 431
nontryptic cleavage sites were not included. All the proteins identified
with a minimum of a single peptide were used to make protein lists for
the pseudopod and for the cell body. A total of 980 proteins was identi-
fied by SEQUEST search. For the proteins with only single peptide match,
relatively high Xcorr values ( 1, 1.8;  2, 2.5;  3, 3.5; Eng et al., 1994)
and probability-based scoring system of peptide identification (Pep
Probe) was used to filter peptide matches, and then every tandem mass
spectroscopy spectra was manually evaluated for final verification pur-
poses. The Xcorr values represent a cross-correlation function used to
provide measurement of similarity between the mass-to-charge ratios for
the fragment ions predicated from amino acid sequences obtained from
the database and the fragment ions actually observed in the tandem mass
spectrum (Eng et al., 1994). Unique proteins in each sample and proteins
showing significant changes ( 50%) in the number of peptides identified
were combined to make a list of enriched proteins in the pseudopodium
and in the cell body. Proteins identified via a single peptide were in-
cluded only if identified in a single compartment. Only those proteins
positively identified in each of the five independent experiments via
MudPIT were included in the list.
Immunofluorescence analysis of Lasp-1 dynamics
NIH 3T3 cells were transfected with the appropriate GFP constructs on
glass coverslips as described above. Cells were washed 2  with PBS, fixed
with 4% PFA in PBS, permeabilized with 0.1% Triton X-100 in PBS for 1
min, and then blocked with 0.5% BSA for 1 h. Anti-vinculin antibodies or
TRITC-conjugated phalloidin (Sigma-Aldrich) was diluted in blocking solu-
tion and incubated with the fixed cells for 60 min. Anti-vinculin–treated
cells were then incubated with Alexa Fluor
® 568–conjugated goat anti–
mouse IgG antibodies and were washed with PBS and mounted on cover-
slips using a ProLong
® anti-fade kit (Molecular Probes, Inc.). Immunofluo-
rescence microscopy was performed using a microscope (model IX70;
Olympus) and data acquisition by a liquid cooled CCD camera (500 KHz,
12 bit, 2MP, KAF1400GI, 1317   1035; model CH350L, Photometrics).
Image data were deconvolved with DeltaVision softWoRx version 2.5 soft-
ware (Applied Precision). To examine the role of Abl activation in Lasp-1
localization to focal adhesions, 2–5  M STI 571 was added to serum-
starved cells for 16 h. Cells were then stimulated for the indicated times
with either 1 mM H2O2, 25  M cisplatin, 2 mM sodium orthovanadate, 20
ng PDGF-BB, or 10% FBS, which was added for 15 min in addition to
other chemicals. Vinculin-positive focal adhesions and the F-actin cyto-
skeleton were examined as described above.
siRNA silencing
21-nucleotide double-stranded RNAs (Dharmacon Research) were synthe-
sized by targeting human Lasp-1 (5 -AACUACAAGGGCUACGAGAAG-3 ;
corresponds to the coding region 127–147 relative to the first nucleotide of
the start codon). Luciferase GL2 duplex (Dharmacon Research) was used as
a negative control. The siRNAs were transfected into Cos-7 cells using Oli-
gofectamine™ (Invitrogen) according to the manufacturer’s instructions.
Specific depletion of Lasp-1 was confirmed 48 h after transfection by West-
ern blotting using anti-Lasp-1 and anti-actin antibodies.
Online supplemental material
A complete list of all pseudopodia and cell body–associated proteins is
shown in Tables S1–S4 and Fig. S1. Materials and methods for cell lines,
plasmids, constructs, antibodies, and cell-based assays, kinase assays, im-
munoprecipitation, and Western blotting are shown. Fig. S1 is a compara-
tive schematic of the number of proteins identified in the each of the
subcompartments of the cell body and pseudopodial fractions. Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200311045/DC1.
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